Search Results - "Piccolini, E."

CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma by Betti, M, Aspesi, A, Biasi, A, Casalone, E, Ferrante, D, Ogliara, P, Gironi, L.C, Giorgione, R, Farinelli, P, Grosso, F, Libener, R, Rosato, S, Turchetti, D, Maffè, A, Casadio, C, Ascoli, V, Dianzani, C, Colombo, E, Piccolini, E, Pavesi, M, Miccoli, S, Mirabelli, D, Bracco, C, Righi, L, Boldorini, R, Papotti, M, Matullo, G, Magnani, C, Pasini, B, Dianzani, I

“…Highlights • Melanoma and mesothelioma show a statistically significant co-occurrence in the general population. • Inherited melanoma and mesothelioma…”
Get full text

Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM) by Castagneto, B., Botta, M., Aitini, E., Spigno, F., Degiovanni, D., Alabiso, O., Serra, M., Muzio, A., Carbone, R., Buosi, R., Galbusera, V., Piccolini, E., Giaretto, L., Rebella, L., Mencoboni, M.

“…Background: The aim of this study was to evaluate the activity and toxicity of pemetrexed and carboplatin combination as first-line chemotherapy in malignant…”
Get full text

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey by Ceresoli, G L, Grosso, F, Zucali, P A, Mencoboni, M, Pasello, G, Ripa, C, Degiovanni, D, Simonelli, M, Bruzzone, A, Dipietrantonj, C, Piccolini, E, Beretta, G D, Favaretto, A G, Giordano, L, Santoro, A, Botta, M

“…Background: The incidence of malignant pleural mesothelioma (MPM) in elderly patients is increasing. There are no specific guidelines for their management…”
Get full text

9146 POSTER Sarcomatoid Malignant Pleural Mesothelioma – a Series of 44 Cases Treated at a Single Oncological Department by Grosso, F, Botta, M, Degiovanni, D, Florio, F, Roveta, A, Libener, R, Piccolini, E, Franzone, P, Bottero, G, Betta, R.G

Get full text

P31 Aurora kinase B: expression and potential therapeutic target in malignant pleural mesothelioma. An in vitro study by Betta, P.-G, Bensi, T, Libener, R, Salvio, M, Arnolfo, E, Ugo, F, Botta, M, Piccolini, E, Orecchia, S

Get full text

6542 POSTER FISH and immunohistochemical analysis of PTEN in human mesothelioma cell lines by Betta, P.G, Libener, R, Salvio, M, Bottero, G, Castagneto, B, Piccolini, E, Orecchia, S

Get full text

XRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control study by Betti, M, Ferrante, D, Padoan, M, Guarrera, S, Giordano, M, Aspesi, A, Mirabelli, D, Casadio, C, Ardissone, F, Ruffini, E, Betta, P G, Libener, R, Guaschino, R, Matullo, G, Piccolini, E, Magnani, C, Dianzani, I

“…Malignant pleural mesothelioma (MPM) is a rare aggressive tumor associated with asbestos exposure. The possible role of genetic factors has also been suggested…”
Get more information

Frequency, patterns and prognostic impact of distant metastases in a large mono-institutional series of malignant pleural mesothelioma (MPM): Not necessarily bad news by Grosso, F., Roveta, A., Gallizzi, G., Muzio, A., Zai, S., Ugo, F., Aurelio, A., Libener, R., Mancuso, M., Ferretti, G., Franzone, P., Pastormerlo, M., Piccolini, E., Degiovanni, D., Numico, G.

Get full text

1-year prospective real life monitoring of asthma control and quality of life in Italy by Terzano, Claudio, Cremonesi, Giovanni, Girbino, Giuseppe, Ingrassia, Eleonora, Marsico, Serafino, Nicolini, Gabriele, Allegra, Luigi

“…The study aimed at prospectively evaluating the evolution of asthma control in Italy, to evaluate the reasons for lack of asthma control, perceived quality of…”
Get full text

Long-term survivors (LS) of malignant pleural mesothelioma (MPM): An effort to gain knowledge of this uncommon biology by Grosso, F., Roveta, A., Bensi, T., Trincheri, N. F., Libener, R., Pavesi, M., Giaretto, L., Piccolini, E., Botta, M., Bottero, G., Mirabelli, D., Betta, P. G.

“…Abstract only…”
Get full text

Aurora B kinase and malignant mesothelioma by Betta, P., Bensi, T., Trincheri, N. F., Arnolfo, E., Libener, R., Botta, M., Piccolini, E., Bottero, G., Grosso, F., Orecchia, S.

“…Abstract only…”
Get full text

Tissue expression of osteopontin (OPN) and mesothelin (MES) in malignant pleural mesothelioma (MPM). An immunohistochemical study of 70 consecutive cases by Betta, P., Libener, R., Orecchia, S., Salvio, M., Arnolfo, E., Bottero, G., Botta, M., Piccolini, E., Pavesi, M.

“…Abstract only e22102 Background: There is still no single test that can reliably identify malignant mesothelial cells. Recently soluble MES and OPN have been…”
Get full text

Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients by Castagneto, Bruno, Zai, Silvia, Mutti, Luciano, Lazzaro, Antonio, Ridolfi, Ruggero, Piccolini, Ezio, Ardizzoni, Andrea, Fumagalli, Luca, Valsuani, Gianni, Botta, Mario

“…Malignant pleural mesothelioma is often unresectable at diagnosis, is refractory to cytotoxic agents and is frequently complicated by pleural effusion. The…”
Get full text

Invasion of the chest wall in primary lung neoplasms by Zanetti, P P, Sorisio, V, Baratta, V, Amerio, G M, Cavanenghi, D, Rosa, G, Zappa, A, Ruscalla, L, Piccolini, E, Conti, P

“…The authors analyse a series of 5 patients who underwent pulmonary and parietal resection between 1990 and 1993 due to non.microcytoma bronchogenic carcinoma…”
Get more information

Clinical observations on the treatment of ischemic cardiac disease with a calcium antagonist: nifedipine by Bufalini, A A, Bargero, G, Botta, M, Marzani, M C, Montalenti, P, Navazzotti, R, Piccolini, E, Marzani, P C

“…Results obtained wih Nifedipine in 146 coronary patients, 85 of them suffering from coronaro-sclerosis with rest and effort stenocardic attacks, and 61 with…”
Get more information